WAVE LIFE SCIENCES LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.26 USD | +6.10% |
|
+11.39% | +23.96% |
| 15/05 | Wells Fargo Starts WAVE Life Sciences With Overweight Rating, $11 Price Target | MT |
| 09/05 | Transcript : Wave Life Sciences Ltd., Q1 2024 Earnings Call, May 09, 2024 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| WAVE LIFE SCIENCES LTD. | Bio Therapeutic Drugs | +6.10% | +11.39% | +23.96% | +70.57% | -76.11% | 72Cr |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- WVE Stock
- Charts Wave Life Sciences Ltd.
- Comparison Chart
